Should we administrate anticoagulants to critically ill patients with new onset supraventricular arrhythmias?

Vincent Labbé; Stephane Ederhy; Muriel Fartoukh; Ariel Cohen

doi:10.1016/j.acvd.2015.01.001

Should we administrate anticoagulants to critically ill patients with new onset supraventricular arrhythmias?

Arch Cardiovasc Dis. 2015 Apr;108(4):217-9. doi: 10.1016/j.acvd.2015.01.001. Epub 2015 Apr 6.

Authors

Vincent Labbé¹, Stephane Ederhy², Muriel Fartoukh³, Ariel Cohen²

Affiliations

¹ Unité de réanimation médico-chirurgicale, pôle thorax voies aériennes, hôpital Tenon, AP-HP, groupe hospitalier des hôpitaux universitaires de l'Est Parisien, Paris, France. Electronic address: [email protected].
² Service de cardiologie, hôpital Saint-Antoine, AP-HP, groupe hospitalier des hôpitaux universitaires de l'Est Parisien, Paris, France.
³ Unité de réanimation médico-chirurgicale, pôle thorax voies aériennes, hôpital Tenon, AP-HP, groupe hospitalier des hôpitaux universitaires de l'Est Parisien, Paris, France.

PMID: 25858533
DOI: 10.1016/j.acvd.2015.01.001

No abstract available

Keywords: Anticoagulation; Arythmie supraventriculaire; Atrial fibrillation; Fibrillation atriale; Intensive care unit; Réanimation; Supraventricular arrhythmias; Thromboembolie; Thromboembolism.

Publication types

Editorial

MeSH terms

Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / mortality
Atrial Flutter / diagnosis
Atrial Flutter / drug therapy*
Atrial Flutter / mortality
Critical Illness
Humans
Odds Ratio
Patient Selection
Predictive Value of Tests
Risk Assessment
Risk Factors
Stroke / mortality
Stroke / prevention & control*
Tachycardia, Supraventricular / diagnosis
Tachycardia, Supraventricular / drug therapy*
Tachycardia, Supraventricular / mortality
Thromboembolism / mortality
Thromboembolism / prevention & control*
Treatment Outcome

Substances

Anticoagulants